Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Other Operating Expenses (2017)

Bone Biologics has reported Other Operating Expenses over the past 2 years, most recently at -$3.5 million for Q2 2017.

  • Quarterly Other Operating Expenses changed N/A to -$3.5 million in Q2 2017 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2017, down 56353.09% year-over-year, with the annual reading at -$2.7 million for FY2017, 56353.09% down from the prior year.
  • Other Operating Expenses was -$3.5 million for Q2 2017 at Bone Biologics, down from $784525.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $784525.0 in Q1 2017 and troughed at -$3.5 million in Q2 2017.